Search Results - Roy M. Matining
- Showing 1 - 6 results of 6
-
1
Metabolic and Immune Activation Effects of Treatment Interruption in Chronic HIV-1 Infection: Implications for Cardiovascular Risk by Pablo Tebas, William Henry, Roy M. Matining, Deborah Weng-Cherng, John L. Schmitz, Hernan Valdez, Nasreen C. Jahed, Laurie Myers, William G. Powderly, David Katzenstein
Published 2008Artigo -
2
Efficacy of a nucleoside-sparing regimen of darunavir/ritonavir plus raltegravir in treatment-naive HIV-1-infected patients (ACTG A5262) by Babafemi Taiwo, Lu Zheng, Sébastien Gallien, Roy M. Matining, Daniel R. Kuritzkes, Cara C. Wilson, Baiba Berzins, Edward P. Acosta, Barbara Bastow, Peter Kim, Joseph J. Eron
Published 2011Artigo -
3
Safety and Antiviral Activity of the HCV Entry Inhibitor ITX5061 in Treatment-Naive HCV-Infected Adults: A Randomized, Double-Blind, Phase 1b Study by Mark Sulkowski, Minhee Kang, Roy M. Matining, David Wyles, Victoria A. Johnson, Gene D. Morse, Valerianna Amorosa, Debika Bhattacharya, Kristine Coughlin, Flossie Wong‐Staal, Marshall J. Glesby
Published 2013Artigo -
4
Safety, Tolerability, and Immunogenicity of Repeated Doses of DermaVir, a Candidate Therapeutic HIV Vaccine, in HIV-Infected Patients Receiving Combination Antiretroviral Therapy by Benigno Rodríguez, David M. Asmuth, Roy M. Matining, John Spritzler, Jeffrey M. Jacobson, Robbie B. Mailliard, Xiao-Dong Li, Ana I. Martínez, Allan R. Tenorio, Franco Lori, Julianna Lisziewicz, Suria Yesmin, Charles R. Rinaldo, Richard B. Pollard
Published 2013Artigo -
5
The Effect of Chloroquine on Immune Activation and Interferon Signatures Associated with HIV-1 by Jeffrey M. Jacobson, Steven E. Bosinger, Minhee Kang, Pablo F. Belaunzarán-Zamudio, Roy M. Matining, Cara C. Wilson, Charles Flexner, Brian Clagett, Jill Plants, Sarah Read, Lynette Purdue, Laurie Myers, Linda Boone, Pablo Tebas, Princy Kumar, David B. Clifford, Daniel C. Douek, Guido Silvestri, Alan Landay, Michael M. Lederman
Published 2016Artigo -
6
Treatment of advanced AIDS-associated Kaposi sarcoma in resource-limited settings: a three-arm, open-label, randomised, non-inferiority trial by Susan E. Krown, Carlee Moser, Patrick MacPhail, Roy M. Matining, Catherine Godfrey, Stephanie Caruso, Mina C. Hosseinipour, Wadzanai Samaneka, Mulinda Nyirenda, Naftali Busakhala, Fred Okuku, Josphat Kosgei, Brenda Hoagland, Noluthando Mwelase, Vincent O Oliver, Henriette Burger, Rosie Mngqibisa, Mostafa Nokta, Thomas Campbell, Margaret Borok, Agnes Moses, Cecilia Kanyama, Pamela Mukwekwerere, Ivy Gudza, Felluna Chauwa, Godwin Ulaya, Irene Kutto, P Cheruiyot, Clement Dove Okello, Annet Nakaganda, Geoffrey Koskei, Winnie Keter, Juliana dos Santos Barbosa Netto, Tamiris Baião, Iveshni Govender, Jessica O'Connell-Maritz, Kevin P. Cain, John Okanda, Lynne Cornelissen, Marije Van Schalkwyk, Rejoice Sikhosana, Minenhle Ngcobo, Jeannette Y. Lee, Taylor Harrison, William Wachsman, Katherine Shin, Scott Evans, Jennifer Rothenberg, Lara Hosey, Seán McCarthy, Otoniel Martı́nez-Maza, Charles R. Rinaldo, Dirk P. Dittmer, Charles R. Rinaldo, Courtney V. Fletcher, Michelle A. Rudek, Aida Asmelash, Valery Hughes, Jeffrey T. Schouten, David Shugarts, Tapiwanashe Kujinga, Amanda Zadzilka, Fredrick Kerui, D.G. Robertson, James Rooney, Krishna Sewal, Brian Gottshall
Published 2020Artigo
Search Tools:
Related Subjects
Internal medicine
Medicine
Immunology
Gastroenterology
Pathology
Alternative medicine
Human immunodeficiency virus (HIV)
Immune system
Placebo
Adverse effect
Antiretroviral therapy
Cohort
Confidence interval
Randomized controlled trial
Viral load
Virology
Virus
Biology
CD34
CD38
CD8
Chloroquine
Cholesterol
Coronavirus disease 2019 (COVID-19)
DNA vaccination
Darunavir
Diabetes mellitus
Disease
ELISPOT
Endocrinology